CD20-positive, follicular Non-Hodgkin's lymphoma grade 1, 2, 3a. A tumor biopsy must have been performed within 6 months before study entry with material available for central review.
CD20-positive, follicular Non-Hodgkin's lymphoma grade 1, 2, 3a. A tumor biopsy must have been performed within 6 months before study entry with material available for central review.
C0054946 (UMLS CUI 2011AA)
82753007 (SNOMED CT 2011_0131)
MTHU001655 (LOINC Version 232)
CL415097 (UMLS CUI 2011AA)
C0024301 (UMLS CUI 2011AA)
277618009, 308121000 (SNOMED CT 2011_0131)
10061170 (MedDRA 14.1)
C82 (ICD-10-CM Version 2010)
202.0 (ICD-9-CM Version 2011)
C0011900 (UMLS CUI 2011AA)
439401001 (SNOMED CT 2011_0131)
MTHU008876 (LOINC Version 232)
C0079765 (UMLS CUI 2011AA)
46744002 (SNOMED CT 2011_0131)
C82.0 (ICD-10-CM Version 2010)
C0079758 (UMLS CUI 2011AA)
55020008 (SNOMED CT 2011_0131)
C82.1 (ICD-10-CM Version 2010)
C3647834 (UMLS CUI 2011AA)
C82.3 (ICD-10-CM Version 2010)
C0006826 (UMLS CUI 2011AA)
363346000 (SNOMED CT 2011_0131)
10028997 (MedDRA 14.1)
MTHU010328 (LOINC Version 232)
C00-C96 (ICD-10-CM Version 2010)
C0005558 (UMLS CUI 2011AA)
86273004 (SNOMED CT 2011_0131)
10004720 (MedDRA 14.1)
MTHU028106 (LOINC Version 232)